SciClone Pharmaceuticals | SciClone Pharmaceuticals | Foreign Corrupt Practices Act | 2016 | SEC | $12,000,000 |
Scios Inc. | Johnson & Johnson | off-label or unapproved promotion of medical products | 2011 | FDA | $85,000,000 |
Seagen Pharmaceuticals, Inc. | Pfizer | benefit plan administrator violation | 2001 | EBSA | $29,974 |
SEARLE LTD | Pfizer | hazardous waste violation | 2002 | EPA | $95,000 |
Serono Inc. | Merck KGaA (EMD) | off-label or unapproved promotion of medical products | 2005 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $262,000,000 |
Serono Laboratories Inc. | Merck KGaA (EMD) | False Claims Act and related | 2011 | DOJ_CIVIL | $44,300,000 |
Serono, S.A. | Merck KGaA (EMD) | off-label or unapproved promotion of medical products | 2005 | FDA | $704,000,000 |
Shering-Plough/Warrick Companies | Merck | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
Shire | Takeda Pharmaceutical | False Claims Act and related | 2013 | LA-AG | $4,000,000 |
SHIRE CORP | Takeda Pharmaceutical | workplace safety or health violation | 2002 | OSHA | $8,100 |
Shire Human Genetic Therapies, Inc. | Takeda Pharmaceutical | environmental violation | 2021 | MA-AG | $600,000 |
Shire LLC | Takeda Pharmaceutical | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $1,850,000 |
Shire Pharmaceuticals LLC | Takeda Pharmaceutical | off-label or unapproved promotion of medical products | 2014 | FDA | $56,500,000 |
Shire Pharmaceuticals LLC | Takeda Pharmaceutical | False Claims Act and related | 2017 | DOJ_CIVIL | $350,000,000 |
Shire Pharmaceuticals LLC | Takeda Pharmaceutical | False Claims Act and related | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $6,104,000 |
Shire Pharmaceuticals LLC | Takeda Pharmaceutical | off-label or unapproved promotion of medical products | 2014 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $20,786,034 |
SHIRE PLC | Takeda Pharmaceutical | workplace safety or health violation | 2016 | OSHA | $19,070 |
Shire US Inc. | Takeda Pharmaceutical | price-fixing or anti-competitive practices | 2016 | private lawsuit-federal | $14,750,000 |
Sigma Aldrich Co. | Merck KGaA (EMD) | air pollution violation | 2004 | USAO | $180,000 |
SIGMA ALDRICH MFG LLC | Merck KGaA (EMD) | air pollution violation | 2007 | EPA | $55,000 |
Sigma Aldrich Research Biochemicals Inc. | Merck KGaA (EMD) | export control violation | 2002 | BIS | $1,760,000 |
SIGMA-ALDRICH | Merck KGaA (EMD) | aviation safety violation | 2011 | FAA | $30,000 |
SIGMA-ALDRICH | Merck KGaA (EMD) | aviation safety violation | 2013 | FAA | $11,000 |
SIGMA-ALDRICH | Merck KGaA (EMD) | workplace safety or health violation | 2018 | OSHA | $23,632 |
SIGMA-ALDRICH CORPORATION | Merck KGaA (EMD) | workplace safety or health violation | 2012 | OSHA | $10,115 |
SIGMA-ALDRICH INC | Merck KGaA (EMD) | aviation safety violation | 2013 | FAA | $8,000 |
SIGMA-ALDRICH MANUFACTURING | Merck KGaA (EMD) | environmental violation | 2014 | IL-ENV | $12,500 |
SIGMA-ALDRICH, INC | Merck KGaA (EMD) | aviation safety violation | 2017 | FAA | $5,000 |
SmithKline Beecham | GlaxoSmithKline | False Claims Act and related | 2003 | DOJ_CIVIL | $47,000,000 |
SmithKline Beecham Corp. | GlaxoSmithKline | price-fixing or anti-competitive practices | 2005 | MULTI-AG | $10,000,000 |
SmithKline Beecham Corp. | GlaxoSmithKline | False Claims Act and related | 2007 | TX-AG | $1,400,000 |
Solvay Pharmaceuticals Inc. | AbbVie | consumer protection violation | 2010 | private lawsuit-federal | $16,500,000 |
St Jude Medical Inc | Abbott Laboratories | wage and hour violation | 2009 | WHD | $17,662 |
St. Jude Medical Inc. | Abbott Laboratories | kickbacks and bribery | 2011 | DOJ_CIVIL | $16,000,000 |
St. Jude Medical Inc. | Abbott Laboratories | False Claims Act and related | 2012 | DOJ_CIVIL | $3,650,000 |
St. Jude Medical Inc. | Abbott Laboratories | False Claims Act and related | 2010 | DOJ_CIVIL | $3,725,000 |
St. Jude Medical Inc. | Abbott Laboratories | drug or medical equipment safety violation | 2021 | DOJ_CIVIL | $27,000,000 |
STERILMED, INC. | Johnson & Johnson | workplace safety or health violation | 2006 | OSHA | $11,278 |
SUN PHARMACEUTICAL INDUSTRIES, INC. | Sun Pharmaceuticals | workplace safety or health violation | 2016 | OSHA | $9,620 |
Sun Pharmaceuticals Industries Ltd | Sun Pharmaceuticals | price-fixing or anti-competitive practices | 2019 | private lawsuit-federal | $400,000 |
Sun Pharmaceuticals Industries Ltd | Sun Pharmaceuticals | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $17,357,000 |
Synthes Inc. | Johnson & Johnson | drug or medical equipment safety violation | 2010 | USAO | $669,800 |
Synthes USA | Johnson & Johnson | wage and hour violation | 2016 | private lawsuit-federal | $5,000,000 |
Synthes, Inc. | Johnson & Johnson | consumer protection violation | 2009 | NJ-AG | $236,000 |
Takeda Chemical | Takeda Pharmaceutical | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $17,551,650 |
Takeda Chemical | Takeda Pharmaceutical | price-fixing or anti-competitive practices | 2000 | CA-AG | $5,850,550 |
Takeda Chemical | Takeda Pharmaceutical | price-fixing or anti-competitive practices | 2002 | MA-AG | $111,167 |
Takeda Chemical | Takeda Pharmaceutical | price-fixing or anti-competitive practices | 2000 | private lawsuit-federal | $22,000,000 |
Takeda Chemical Industries Ltd. | Takeda Pharmaceutical | price-fixing or anti-competitive practices | 2003 | private lawsuit-federal | $22,000,000 |
Takeda Pharmaceutical Co. Ltd. | Takeda Pharmaceutical | drug or medical equipment safety violation | 2015 | private lawsuit-federal | $2,400,000,000 |
Takeda Pharmaceuticals | Takeda Pharmaceutical | False Claims Act and related | 2008 | AL-AG | $2,000,000 |
Takeda Pharmaceuticals | Takeda Pharmaceutical | benefit plan administrator violation | 2023 | private lawsuit-federal | $22,000,000 |
Takeda Pharmaceuticals | Takeda Pharmaceutical | False Claims Act and related | 2023 | TX-AG | $21,350,000 |
Takeda Pharmaceuticals U.S.A. | Takeda Pharmaceutical | False Claims Act and related | 2019 | IL-AG | $5,833,333 |
Takeda/Tap Pharmaceuticals | Takeda Pharmaceutical | False Claims Act and related | 2013 | LA-AG | $3,750,000 |
TAP Pharmaceutical Products | Takeda Pharmaceutical | False Claims Act and related | 2011 | PA-AG | $5,240,797 |
TAP Pharmaceutical Products | Takeda Pharmaceutical | price-fixing or anti-competitive practices | 2005 | private lawsuit-federal | $150,000,000 |
TAP Pharmaceutical Products Inc. | Takeda Pharmaceutical | False Claims Act and related | 2001 | DOJ_CIVIL | $875,000,000 |
TAP Pharmaceutical Products, Inc. | Takeda Pharmaceutical | False Claims Act and related | 2001 | AR-AG | $525,780 |
TAP Pharmaceutical Products, Inc. | Takeda Pharmaceutical | consumer protection violation | 2006 | ID-AG | $198,000 |
TAP Pharmaceutical Products, Inc. | Takeda Pharmaceutical | kickbacks and bribery | 2006 | KY-AG | $600,000 |
TAP Pharmaceutical Products, Inc. | Takeda Pharmaceutical | kickbacks and bribery | 2006 | WI-AG | $798,000 |
TAP Pharmaceutical Products, Inc. | Takeda Pharmaceutical | False Claims Act and related | 2001 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $25,516,440 |
Taro Pharmaceutical Industries | Sun Pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $5,000,000 |
Taro Pharmaceutical USA Inc. | Sun Pharmaceuticals | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $67,643,000 |
Taro Pharmaceuticals USA, Inc. | Sun Pharmaceuticals | False Claims Act and related | 2014 | TX-AG | $8,750,000 |
Taro Pharmaceuticals USA, Inc. | Sun Pharmaceuticals | False Claims Act and related | 2021 | DOJ_CIVIL | $213,200,000 |
TARO PHARMACEUTICALS USA, INC. | Sun Pharmaceuticals | workplace safety or health violation | 2019 | OSHA | $18,565 |
Teva | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2024 | MD-AG | $70,281,867 |
Teva Parmaceuticals | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | CA-SFCA | $27,000,000 |
TEVA PHARMACEUTICAL | Teva Pharmaceutical Industries | workplace safety or health violation | 2000 | OSHA | $5,000 |
Teva Pharmaceutical Industries | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | FL-AG | $278,826,499 |
Teva Pharmaceutical Industries | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | RI-AG | $21,000,000 |
Teva Pharmaceutical Industries | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | WV-AG | $83,000,000 |
Teva Pharmaceutical Industries | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $8,200,000 |
Teva Pharmaceutical Industries Limited | Teva Pharmaceutical Industries | Foreign Corrupt Practices Act | 2016 | SEC | $236,000,000 |
Teva Pharmaceutical Industries Ltd | Teva Pharmaceutical Industries | Foreign Corrupt Practices Act | 2016 | DOJ_CRIMINAL | $283,177,348 |
Teva Pharmaceutical Industries Ltd. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2019 | CA-AG | $69,000,000 |
Teva Pharmaceutical Industries Ltd. | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | TX-AG | $225,000,000 |
Teva Pharmaceutical USA, Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2009 | MA-AG | $7,000,000 |
TEVA PHARMACEUTICAL USA, INC. | Teva Pharmaceutical Industries | workplace safety or health violation | 2016 | OSHA | $5,000 |
Teva Pharmaceuticals | Teva Pharmaceutical Industries | Controlled Substances Act violation | 2019 | OK-AG | $85,000,000 |
Teva Pharmaceuticals | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $4,250,000,000 |
Teva Pharmaceuticals Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2010 | MULTI-AG | $169,000,000 |
Teva Pharmaceuticals Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2019 | private lawsuit-federal | $54,000,000 |
TEVA PHARMACEUTICALS INC. | Teva Pharmaceutical Industries | workplace safety or health violation | 2002 | OSHA | $15,300 |
Teva Pharmaceuticals Industries Ltd. | Teva Pharmaceutical Industries | product safety violation | 2012 | private lawsuit-federal | $270,000,000 |
TEVA Pharmaceuticals USA | Teva Pharmaceutical Industries | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
Teva Pharmaceuticals USA | Teva Pharmaceutical Industries | environmental violation | 2013 | MO-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,402,793 |
TEVA PHARMACEUTICALS USA INC | Teva Pharmaceutical Industries | air pollution violation | 2006 | NJ-ENV | $6,200 |
TEVA PHARMACEUTICALS USA INC | Teva Pharmaceutical Industries | air pollution violation | 2013 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,250,000 |
Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | air pollution violation | 2013 | EPA | $2,250,000 |
Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | kickbacks and bribery | 2014 | IL-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $12,100,000 |
Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | environmental violation | 2003 | MO-AG | $70,000 |
Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2015 | private lawsuit-federal | $512,000,000 |
Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $27,000,000 |
Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2017 | private lawsuit-federal | $73,000,000 |
Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2015 | private lawsuit-federal | $24,000,000 |
Teva Pharmaceuticals USA Inc. and IVAX LLC | Teva Pharmaceutical Industries | False Claims Act and related | 2014 | DOJ_CIVIL | $27,600,000 |
Teva Pharmaceuticals USA Inc., IVAX Corporation, IVAX Pharmaceuticals Inc., Sicor Inc., Barr Laboratories Inc. and Duramed Pharmaceuticals Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2010 | KY-AG | $10,000,000 |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2014 | NY-AG | $150,000 |